BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $4354.20.64 only $1741.68

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.59
0.00%
US Tech 100
20,306.40
0.21%
S&P 500
5,987.37
0.30%
US Dollar vs CAD
1.40814
-0.01%
Bitcoin
92,175.09
-0.98%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. XTL Biopharmaceuticals Ltd (XTLB)

  7. XTL Biopharmaceuticals Ltd (XTLB) Financials

XTL Biopharmaceuticals Ltd

XTL Biopharmaceuticals Ltd (XTLB)

NASDAQ
1.88
0.00
(0.00%)
Closed November 25 3:00PM
Delayed by 15 minutes
1.88
0.00
( 0.00% )
Pre Market: 5:21AM
Delayed by 15 minutes

XTL Biopharmaceuticals Ltd Financial Summary

The current XTLB market cap is 10.24M. The company's latest EPS is USD and P/E is N/A.

Income Statement

Annual Quarterly
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -225k-251k-163k-151k-200k
Net Income -748k-919k-364k-215k-284k
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -842k-948k-1.03M-880k-765k
Net Income -1.35M-782k435k-1.35M-1.78M

Balance Sheet

Annual Quarterly
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 4.19M3.32M2.88M2.66M2.43M
Total Liabilities 187k241k163k162k206k
Total Equity 4M3.08M2.72M2.5M2.22M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 7.21M6.5M6.62M4.19M2.43M
Total Liabilities 232k254k1.29M187k206k
Total Equity 6.98M6.25M5.33M4M2.22M

Cash Flow

Annual Quarterly
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -901k N/A N/A N/A -707k
Investing 36k N/A N/A N/A 41k
Financing N/A N/A N/A N/A N/A
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -908k-850k2.87M-901k-707k
Investing 2.11M32k8k36k41k
Financing N/A N/A 385k N/A N/A

Stats and Ratios

Market Cap 10.24M
Price to Earnings Ratio N/A
Price to Sales Ratio 0
Price to Cash Ratio 0
Price to Book Ratio 0
Dividend Yield -

Share Statistics

Shares Outstanding 5.45M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.26 (13.9%)

Company Info

Company Name XTL Biopharmaceuticals Ltd
Address 5 badner st
ramat gan, center 5218102
Website https://www.xtlbio.com
Industry pharmaceutical preparations (2834)

Your Recent History

NASDAQ
XTLB
XTL Biopharmaceuticals
BIT
AIGI
ETFS Industrial Metals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Canada: TSX and TSXV Level 1

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1305.00 only $522.00